Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands
Department of Pediatrics, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands.
BMJ Paediatr Open. 2023 Jan;7(1). doi: 10.1136/bmjpo-2022-001677.
Paediatric palliative care (PPC) is care for children with life-threatening or life-limiting conditions, and can involve complex high-tech care, which can last for months or years. In 2015, the National Individual Care Plan (ICP) for PPC was developed and has shown to be successful. The ICP can be seen as an instrument to facilitate coordination, quality and continuity of PPC. However, in practice, an ICP is often completed too late and for too few children. We aim to improve the coordination, quality and continuity of care for every child with a life-threatening or life-limiting condition and his/her family by further developing and implementing the ICP in the Netherlands.
To evaluate the original ICP, ICP 1.0, interviews and questionnaires will be held among parents of children who have or have had an ICP 1.0 and healthcare professionals (HCPs) who used ICP 1.0. Based on the results, ICP 1.0 will be further developed. An implementation strategy will be written and the renewed ICP, ICP 2.0, will be nationally tested in an implementation period of approximately 7 months. During the implementation period, ICP 2.0 will be used for all children who are registered with Children's Palliative Care teams. After the implementation period, ICP 2.0 will be evaluated using interviews and questionnaires among parents of children who received ICP 2.0 and HPCs who worked with ICP 2.0. Based on these results, ICP 2.0 will be further optimised into the final version: ICP 3.0.
This study received ethical approval. The ICP 3.0 will be disseminated through the Dutch Centre of Expertise in Children's Palliative Care, to ensure wide availability for the general public and HCPs within PPC. Additionally, we aim to publish study results in open-access, peer-reviewed journals and to present results at national and international scientific meetings.
儿科姑息治疗(PPC)是为患有危及生命或生命有限的疾病的儿童提供的护理,可以包括复杂的高科技护理,持续数月或数年。2015 年,制定了国家个人护理计划(ICP),并已证明该计划是成功的。ICP 可以被视为促进 PPC 协调、质量和连续性的工具。然而,在实践中,ICP 通常为太少的儿童完成得太晚。我们的目标是通过进一步开发和实施荷兰的 ICP 来改善每个患有危及生命或生命有限的疾病的儿童及其家庭的护理协调、质量和连续性。
为了评估原始的 ICP(ICP1.0),我们将对拥有或曾经拥有 ICP1.0 的儿童的父母和使用 ICP1.0 的医疗保健专业人员(HCPs)进行访谈和问卷调查。根据结果,我们将进一步开发 ICP1.0。将编写实施策略,并在大约 7 个月的实施期内在全国范围内测试更新后的 ICP(ICP2.0)。在实施期间,将为所有在儿童姑息治疗团队注册的儿童使用 ICP2.0。实施期结束后,将对使用 ICP2.0 的儿童的父母和使用 ICP2.0 的 HPCs 进行访谈和问卷调查,以评估 ICP2.0。基于这些结果,我们将进一步优化 ICP2.0 进入最终版本:ICP3.0。
这项研究获得了伦理批准。ICP3.0 将通过荷兰儿童姑息治疗中心传播,以确保普通公众和 PPC 内的 HCPs 广泛获得。此外,我们的目标是在开放获取、同行评议的期刊上发表研究结果,并在国家和国际科学会议上展示结果。